Insider Transactions Reported by 19 Insiders of Cyteir Therapeutics, Inc.

Location
Stoneham, MA

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Cyteir Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Braden M Leonard 10%+ Owner $11,767,706 20 Mar 2024
Invest II SCSp Droia 10%+ Owner $5,977,197 22 Jun 2021
Novo Holdings A/S 10%+ Owner $5,952,410 19 Jul 2023
Venrock Associates VII, L.P. 10%+ Owner $5,507,752 22 Jun 2021
Jean George Director $4,154,722 14 Feb 2024
MARKUS RENSCHLER MD President and CEO, Director $1,865,187 29 Feb 2024
Joseph S. Zakrzewski Director $636,268 06 Feb 2024
David G. Gaiero Chief Financial Officer $173,041 29 Feb 2024
JOHN F. THERO Director $38,579 08 Feb 2024
Stephen H. Sands Director $20,498 09 Feb 2024
Janwillem Naesens Director 22 Feb 2022
Jeffrey Humphrey Director 03 Feb 2023
Andrew Gengos Chief Business Officer 22 Feb 2022
Racquel Bracken Director 03 Feb 2023
Karen Hong Director 17 Jun 2021
Timothy Romberger Director 03 Feb 2023
John Paul Secrist Chief Scientific Officer 22 Feb 2022
Adam M. Veness General Counsel 03 Feb 2023
Susan Molineaux Director 03 Feb 2023

Recent Insider Transactions by Companies or Individuals for Cyteir Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.